This study illustrates possible influences of consumption of ethanol on the pharmacokinetic behaviour of inhaled trichloroethylene (TRI) in relation to biological monitoring of exposure. The results were obtained for a standard male worker of 70 kg by physiologically based pharmacokinetic modelling. Depending on the pattern of consumption of ethanol, enzyme inhibition or induction was assumed to prevail in this worker. The inhibition and induction were modelled by assuming competitive metabolic interaction between TRI and ethanol and increased maximum velocity (Vmax) of TRI metabolism respectively. Ingestion of moderate amounts of ethanol before the start of work or at lunch time, but not at the end of work, caused pronounced increases in blood TRI concentrations and decreases in the urinary excretion rates of TRI metabolites, this effect lasting until the next day. The effects were smaller the higher the exposure concentration of TRI. Induction of TRI metabolism, supposedly by consumption of ethanol the previous evening, caused only small changes in the pharmacokinetic profile at 50 ppm, but appreciable changes at 500 ppm.
The metabolism of organic solvents is important from two aspects.' Firstly, metabolism is the major factor responsible for the disappearance of solvents from the body. Thus a change in the metabolism may alter their pharmacokinetic behaviour and consequently affect the results of biological monitoring of exposure to solvents. Secondly, biotransformation sometimes results in the production of highly reactive intermediates that can bind covalently to critical components of the target cell. Such bioactivation is responsible for some health hazards caused by environmental chemicals including trichloroethylene (TRI) induced hepatotoxicity.
Enzymes regulating the biotransformation are cytochrome P-450 related mono-oxygenases, which are found at the highest concentration in the liver.' The metabolic pathway whereby the cytochrome P-450 system is involved is considered to be a rate limiting step in the overall metabolic processes. This enzyme system is known to be susceptible to the influence of various environmental factors including nutritional state, medicines, and exposure to environmental chemicals.
Consumption of alcohol is probably one of the most important environmental factors that affect the metabolism of organic solvents, as ethanol is the only biologically active substance that many people, including those who are occupationally exposed to organic solvents, frequently consume in multigram quantities. Some industrial workers may drink large quantities of alcoholic beverages in the evening and are then exposed to organic solvent vapours at work the next day. Others (fig 2A and B) . The effect on the TTC excretion increased by about 70% (fig lA and B 10% (fig 4B) . At 500 ppm, however, the TRI concentration was reduced by almost 50% and the rate of urinary TTC excretion was almost doubled (fig 4A) . A further increase of Vmax from 16 to 32 mg/min (from a five to 10-fold increase) produced only a marginal influence on the kinetic profiles at these exposure concentrations, a finding which suggests that TRI metabolism is not limited by the intrinsic capacity of the enzymes. resulted in an almost fivefold increase in concentration of urinary metabolites at this exposure level. These results suggest that a shift from perfusion to capacity limited metabolism occurs as the exposure concentration increases and that under the influence of enzyme induction this shift occurs at a higher concentration. Experimental evidence has shown that administration of ethanol to rats acutely9 or chronically"8 accelerates the hepatic metabolism in vitro of various volatile hydrocarbons. The induction of a unique form of cytochrome P-450, P-450IIE1'9 by ethanol is responsible, at least in part, for this enhancement of metabolism. This isozyme, which has been referred to as P-450ac20 or P-450j,2' has a specifically high affinity for volatile, low molecular weight substances represented by organic solvents.22 Vmax/(Km + CH) is smaller than hepatic blood flow, the enzyme capacity is the rate limiting factor (capacity limited metabolism). Therefore, the hepatic metabolism in vivo at low dose exposures (CH is small) can often be rate limited by the hepatic blood flow. This may be especially true with the metabolism under the influence of enzyme induction (Vmax is large).
Discussion
The effect ofenzyme induction on TRI metabolism in vivo thus depends on the exposure concentration ( fig 5) . At low exposure concentrations where the hepatic blood flow rate limits the metabolism, a fivefold increase in Vmax caused only a marginal influence on the TRI metabolism (fig 4) . Such a small effect of an appreciable enzyme induction can be explained by the similarity in values of hepatic blood flow (1 4 1/min) and intrinsic metabolic clearance (Vmax/Km = 1 3 1/min) in our model (10% difference). The enzyme induction was not fully reflected in the metabolism in vivo until the exposure concentration reached 1000 ppm or higher. In view of biological monitoring of exposure it is noteworthy that enzyme induction due to drinking ethanol may not affect the pharmacokinetic behaviour of organic solvents as much as animal studies conducted in vivo and in vitro suggest.
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